Growth Metrics

Prestige Consumer Healthcare (PBH) Capital Expenditures (2016 - 2025)

Prestige Consumer Healthcare has reported Capital Expenditures over the past 16 years, most recently at $3.0 million for Q4 2025.

  • For Q4 2025, Capital Expenditures rose 93.36% year-over-year to $3.0 million; the TTM value through Dec 2025 reached $9.4 million, up 19.76%, while the annual FY2025 figure was $8.2 million, 13.88% down from the prior year.
  • Capital Expenditures for Q4 2025 was $3.0 million at Prestige Consumer Healthcare, up from $2.1 million in the prior quarter.
  • Over five years, Capital Expenditures peaked at $4.9 million in Q1 2021 and troughed at $838000.0 in Q2 2025.
  • A 5-year average of $2.3 million and a median of $2.2 million in 2021 define the central range for Capital Expenditures.
  • Biggest five-year swings in Capital Expenditures: tumbled 69.64% in 2021 and later skyrocketed 93.36% in 2025.
  • Year by year, Capital Expenditures stood at $2.2 million in 2021, then dropped by 19.11% to $1.8 million in 2022, then rose by 10.7% to $2.0 million in 2023, then decreased by 21.54% to $1.6 million in 2024, then skyrocketed by 93.36% to $3.0 million in 2025.
  • Business Quant data shows Capital Expenditures for PBH at $3.0 million in Q4 2025, $2.1 million in Q3 2025, and $838000.0 in Q2 2025.